Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 5/20 | 0.78 |
| ▸ | CHRM2 | P08172 | 4/20 | 0.78 |
| ▸ | ADRA2A | P08913 | 4/20 | 0.78 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.78 |
| ▸ | DRD3 | P35462 | 4/20 | 0.78 |
| ▸ | HRH1 | P35367 | 3/20 | 0.78 |
| ▸ | OPRK1 | P41145 | 3/20 | 0.78 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.78 |
| ▸ | DRD1 | P21728 | 3/20 | 0.78 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.78 |
| ▸ | SLC6A4 | P31645 | 3/20 | 0.78 |
| ▸ | SLC6A3 | Q01959 | 3/20 | 0.78 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.78 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.78 |
| ▸ | CNR1 | P21554 | 2/20 | 0.78 |
| ▸ | GHSR | Q92847 | 2/20 | 0.78 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.78 |
| ▸ | USP2 | O75604 | 2/20 | 0.78 |
| ▸ | DRD2 | P14416 | 2/20 | 0.78 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL588110 | 1.00 | KCNH2 (0.78) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| SCHEMBL588111 | 1.00 | KCNH2 (0.78) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| Hydrochloric Acid SCHEMBL588103 | 0.98 | LMNA (0.79) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| Hydrochloric Acid SCHEMBL587709 | 0.98 | LMNA (0.79) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| Hydrochloric Acid SCHEMBL588128 | 0.98 | LMNA (0.79) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| SCHEMBL12464946 | 0.97 | KCNH2 (0.80) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| SCHEMBL7311276 | 0.92 | ATM (0.84) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| Hydrochloric Acid SCHEMBL16226937 | 0.90 | ATM (0.82) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| SCHEMBL9720751 | 0.90 | KCNH2 (0.71) | KCNH2CHRM2ADRA2AADRA1ADRD3 | |
| Meclizine SCHEMBL4649 | 0.88 | KCNH2 (1.00) | KCNH2CHRM2ADRA2AADRA1ADRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7851627-B2 | Optically active carbamates, process for preparation thereof and use thereof as pharmaceutical intermediates | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2010-12-14 | — | — | US | claimed |
| US-20090221823-A1 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES | EGIS GYOGYSZERGYAR NYILVANOSAN MUKODO RESZVENYTARSASAG (HU) | 2009-09-03 | — | — | US | claimed |
| EP-1963296-A2 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES | Egis Gyógyszergyár Nyilvánosan Múködö Részvénytársaság (HU) | 2008-09-03 | — | — | EP | claimed |
| WO-2007066163-A2 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES | Egis Gyógyszergyár Nyilvanosan Mukodo Reszvenytarsasag (HU) | 2007-06-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221823-A1 | OPTICALLY ACTIVE CARBAMATES, PROCESS FOR PREPARATION THEREOF AND USE THEREOF AS PHARMACEUTICAL INTERMEDIATES | HRH4, HRH1, HRH2 | KCNH2 258/4885CHRM2 88/4885ADRA2A 440/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.